[1]
S. Chatio, “Patients experiences on the use of dihydroartemisinin piperaquine as an alternative first line artemisinin-based combination treatment for uncomplicated malaria in Northern Ghana”, Int J Clin Trials, vol. 6, no. 2, pp. 39–44, Apr. 2019.